Obstetricians and gynecologists from Columbia and Weill Cornell Medicine are leaders in advancing the health and well-being of women and delivering personal, compassionate, and high-quality care throughout their life cycle. Their research initiatives meet the needs of all women with a focus on improving clinical outcomes, reducing maternal mortality, and facilitating patient access to care.
Women's Health (OB/GYN)
Featured Updates
On this episode of Advances in Care, Erin Welsh is joined by Dr. Lawrence Lustig, chair of the Department of Otolaryngology – Head & Neck Surgery at NewYork-Presbyterian and Columbia. Dr. Lustig has spent decades working to advance various interventions to treat genetic hearing loss and after years of research his team was the first to show that gene therapies could be effective at reversing genetic hearing loss in mouse models and eventually, humans. In April 2026, the FDA approved the first ever gene therapy for genetic deafness based on the work pushed forward by Dr. Lustig.









